184 related articles for article (PubMed ID: 31486033)
1. Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer.
Villa NY; Franco LS; McFadden G
Methods Mol Biol; 2020; 2058():95-110. PubMed ID: 31486033
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.
Ashton LV; Quackenbush SL; Castle J; Wilson G; McCoy J; Jordan M; MacNeill AL
Viruses; 2020 May; 12(5):. PubMed ID: 32397134
[TBL] [Abstract][Full Text] [Related]
3. Myxoma virus expressing human interleukin-12 does not induce myxomatosis in European rabbits.
Stanford MM; Barrett JW; Gilbert PA; Bankert R; McFadden G
J Virol; 2007 Nov; 81(22):12704-8. PubMed ID: 17728229
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.
Villa NY; Bais S; Chan WM; Meacham AM; Wise E; Rahman MM; Moreb JS; Rosenau EH; Wingard JR; McFadden G; Cogle CR
Cytotherapy; 2016 Mar; 18(3):465-80. PubMed ID: 26857235
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic myxoma virus: the path to clinic.
Chan WM; Rahman MM; McFadden G
Vaccine; 2013 Sep; 31(39):4252-8. PubMed ID: 23726825
[TBL] [Abstract][Full Text] [Related]
6. Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expression.
Smallwood SE; Rahman MM; Werden SJ; Martino MF; McFadden G
Curr Protoc Microbiol; 2011 May; Chapter 14():Unit 14A.2. PubMed ID: 21538302
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of autologous bone marrow pre-loaded
Villa NY; Rahman MM; Mamola J; Sharik ME; de Matos AL; Kilbourne J; Lowe K; Daggett-Vondras J; D'Isabella J; Goras E; Chesi M; Bergsagel PL; McFadden G
Oncotarget; 2022; 13():490-504. PubMed ID: 35251496
[TBL] [Abstract][Full Text] [Related]
8. Methods for the Construction of Recombinant Oncolytic Myxoma Viruses.
Torres-Domínguez LE; de Matos AL; Rahman MM; McFadden G
Methods Mol Biol; 2021; 2225():63-75. PubMed ID: 33108657
[TBL] [Abstract][Full Text] [Related]
9. The current status and future directions of myxoma virus, a master in immune evasion.
Spiesschaert B; McFadden G; Hermans K; Nauwynck H; Van de Walle GR
Vet Res; 2011 Jun; 42(1):76. PubMed ID: 21658227
[TBL] [Abstract][Full Text] [Related]
10. Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells.
Villa NY; Wasserfall CH; Meacham AM; Wise E; Chan W; Wingard JR; McFadden G; Cogle CR
Blood; 2015 Jun; 125(24):3778-88. PubMed ID: 25904246
[TBL] [Abstract][Full Text] [Related]
11. Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways.
Rahman MM; McFadden G
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32456120
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Virotherapy with Myxoma Virus.
Rahman MM; McFadden G
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936317
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.
Madlambayan GJ; Bartee E; Kim M; Rahman MM; Meacham A; Scott EW; McFadden G; Cogle CR
Leuk Res; 2012 May; 36(5):619-24. PubMed ID: 22341701
[TBL] [Abstract][Full Text] [Related]
14. Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.
Liu J; Wennier S; Reinhard M; Roy E; MacNeill A; McFadden G
J Virol; 2009 Jun; 83(11):5933-8. PubMed ID: 19279088
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Myxoma Virus C7-Like Host Range Factor That Enabled a Species Leap from Rabbits to Hares.
Águeda-Pinto A; Kraberger S; Everts A; Gutierrez-Jensen A; Glenn HL; Dalton KP; Podadera A; Parra F; Martinez-Haro M; Viñuelas JA; Varsani A; McFadden G; Rahman MM; Esteves PJ
mBio; 2022 Apr; 13(2):e0346121. PubMed ID: 35352978
[TBL] [Abstract][Full Text] [Related]
16. In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.
McKenzie BA; Zemp FJ; Pisklakova A; Narendran A; McFadden G; Lun X; Kenchappa RS; Kurz EU; Forsyth PA
Neuro Oncol; 2015 Aug; 17(8):1086-94. PubMed ID: 25605818
[TBL] [Abstract][Full Text] [Related]
17. Genetic Characterization of a Recombinant Myxoma Virus in the Iberian Hare (
Águeda-Pinto A; Lemos de Matos A; Abrantes M; Kraberger S; Risalde MA; Gortázar C; McFadden G; Varsani A; Esteves PJ
Viruses; 2019 Jun; 11(6):. PubMed ID: 31181645
[TBL] [Abstract][Full Text] [Related]
18. Detection of recombinant Hare Myxoma Virus in wild rabbits (
Abade Dos Santos FA; Carvalho CL; Pinto A; Rai R; Monteiro M; Carvalho P; Mendonça P; Peleteiro MC; Parra F; Duarte MD
Viruses; 2020 Oct; 12(10):. PubMed ID: 33028004
[TBL] [Abstract][Full Text] [Related]
19. Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.
Weng M; Gong W; Ma M; Chu B; Qin Y; Zhang M; Lun X; McFadden G; Forsyth P; Yang Y; Quan Z
Mol Cancer; 2014 Apr; 13():82. PubMed ID: 24725816
[TBL] [Abstract][Full Text] [Related]
20. Recombinant myxoma virus infection associated with high mortality in rabbit farming (Oryctolagus cuniculus).
Abade Dos Santos FA; Carvalho CL; Monteiro M; Carvalho P; Mendonça P; Peleteiro MDC; Duarte MD
Transbound Emerg Dis; 2021 Jul; 68(4):2616-2621. PubMed ID: 33119958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
